Elutia (ELUT) Depreciation and Depletion (2024 - 2025)

Elutia (ELUT) reported Depreciation and Depletion of $100000.0 for Q4 2025, little changed on a YoY basis from $100000.0 in Q4 2024, and little changed sequentially from $100000.0 in Q4 2024.

Elutia (ELUT) Depreciation and Depletion (2024 - 2025) Analysis & Trends

Elutia (ELUT) has 2 years of Depreciation and Depletion data on file, last reported at $100000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Depreciation and Depletion changed 0.0% year-over-year to $100000.0; the trailing twelve-month figure through Dec 2025 stood at $100000.0 (changed 0.0% YoY), and the FY2025 full-year result was $100000.0, changed 0.0% from the prior year.
  • Depreciation and Depletion held at $100000.0 in Q4 2025, from $100000.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $100000.0 in Q4 2024 to a low of $100000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 381.00 Mn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 120.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 308.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 89.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 78.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Elutia 39.99 Mn 11.50 Mn 1.80 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 100,000.00
Dec 31, 2025 100,000.00
Dec 31, 2024 100,000.00
Dec 31, 2024 100,000.00